HMGCS2 and colorectal cancer: To further confirm the decrease of HMGCS2 expression by Wnt/β-catenin pathway activation, LS174 and Caco2 cells were treated with LiCl, which activates Wnt/β-catenin signaling by inhibiting GSK3β activity in normal and colorectal cancer cells [39,40].